Ex vivo embryonic liver explant culture is a novel and attractive approach
to obtain abundant hepatic and hematopoietic stem cells. Gene therapy of au
tologous hepatic and hematopoietic stem cells represents an alternative the
rapeutic approach to liver transplantation for genetic and metabolic disord
ers. In this study we characterize the growth and differentiation of hepati
c stem cells utilizing embryonic liver cultures. Day 9.5 liver buds are mic
rodissected and cultured under specific conditions. Modulation of growth co
nditions by addition of hepatocyte growth factor, Flt-3 ligand, and stem ce
ll factor leads to enrichment of hepatic progenitor cells in embryonic live
r explants. Under these conditions, we also demonstrate the role of a novel
marker PRAJA-1 to identify hepatic stem cells and transitional hepatocytes
. Utilization of dexamethasone enhanced pseudolobule formation with increas
ed hepatocytic and biliary differentiation. Transforming growth factor-beta
leads to enrichment of biliary cells in the culture, Gut formation is enha
nced in the presence of interleukin-3 and blood formation by increasing the
mesodermal tissue in these cultures. We also show increased retroviral-med
iated expression of the green fluorescent protein expression in the expande
d hepatic and hematopoietic stem cells under different culture conditions.
Thus, the embryonic liver explant culture is an attractive source for hepat
ic progenitors and is a possible step towards generating nontumorigenic imm
ortalized hepatocytes with possible transplantation applications.